Intellectus Partners LLC lessened its position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 17.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 6,577 shares of the company’s stock after selling 1,400 shares during the period. Intellectus Partners LLC’s holdings in DocuSign were worth $592,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in DOCU. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign in the 3rd quarter worth about $28,000. Kestra Investment Management LLC purchased a new position in DocuSign in the 4th quarter worth about $30,000. Brooklyn Investment Group purchased a new position in DocuSign in the 3rd quarter worth about $33,000. Modus Advisors LLC purchased a new position in DocuSign in the 4th quarter worth about $36,000. Finally, First Horizon Advisors Inc. increased its stake in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after buying an additional 201 shares during the period. Institutional investors own 77.64% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently commented on the stock. Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Wells Fargo & Company raised their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Friday, December 6th. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Robert W. Baird raised their price target on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, Piper Sandler raised their target price on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $92.45.
DocuSign Stock Up 0.1 %
Shares of DocuSign stock opened at $79.83 on Friday. The firm’s 50 day moving average price is $89.05 and its 200-day moving average price is $78.60. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The company has a market cap of $16.13 billion, a P/E ratio of 16.46, a PEG ratio of 6.94 and a beta of 1.02.
Insider Transactions at DocuSign
In other news, CEO Allan C. Thygesen sold 40,000 shares of DocuSign stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total value of $3,601,600.00. Following the transaction, the chief executive officer now owns 156,050 shares of the company’s stock, valued at $14,050,742. The trade was a 20.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the transaction, the director now directly owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 686,010 shares of company stock valued at $66,102,694 in the last 90 days. Insiders own 1.66% of the company’s stock.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- What Are Some of the Best Large-Cap Stocks to Buy?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Consumer Discretionary Stocks Explained
- 3 Stocks to Buy While Others Stay on the Sidelines
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.